Morocco · Delayed Price · Currency is MAD Société de Therapeutique Marocaine Company Description
Société de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing of licensed medicines in Morocco.
It offers products in various therapeutic areas, such as allergology, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, central nervous system (CNS), and urology, as well as antibiotics and generics.
The company also provides its products in various forms, including tablets, capsules, pouches, syrups, suspensions, powders, collyriums, flexible pouches, suppositories, creams and pomades, injectable solutions, and self-injectable syringes.
In addition, it imports licensed medicines and dental products, as well as biotechnology products; and involved in subcontracted production.
The company exports its products to Europe, Maghreb, Sub-Saharan Africa, and the Persian Gulf. Société de Therapeutique Marocaine S.A. was founded in 1976 and is based in Bouskoura, Morocco.
| Country | Morocco |
| Founded | 1976 |
| Industry | Pharmaceutical Preparations |
| Employees | 1,316 |
| CEO | Lamia Tazi |
Contact Details
Address: Zone industrielle de Bouskoura Bouskoura, 27182 Morocco | |
| Phone | 212 5 22 43 70 40 |
| Website | sothema.com |
Stock Details
| Ticker Symbol | SOT |
| Exchange | Casablanca Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | MAD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Lamia Tazi | Chief Executive Officer |
| Adnane Hilal | Chief Financial Officer |
| Mehdi Zaghloul | Chief Operating Officer |